Vaccine Safety Datalink Publications

Kharbanda EO, Vazquez-Benitez G, Romitti PA et al. Identifying birth defects in automated data sources in the Vaccine Safety Datalink. Pharmacoepidemiol Drug Saf 2017.   https://www.ncbi.nlm.nih.gov/pubmed/28054412

Hambidge SJ, Ross C, Shoup JA et al. Integration of data from a safety net health care system into the Vaccine Safety Datalink. Vaccine 2017. https://www.ncbi.nlm.nih.gov/pubmed/28161424

Klein NP, Lewis E, McDonald J et al. Risk factors and familial clustering for fever 7-10 days after the first dose of measles vaccines. Vaccine 2017;35:1615-1621.   https://www.ncbi.nlm.nih.gov/pubmed/28233624

Daley MF, Glanz JM, Newcomer SR et al. Assessing misclassification of vaccination status: Implications for studies of the safety of the childhood immunization schedule. Vaccine 2017;35:1873-1878. https://www.ncbi.nlm.nih.gov/pubmed/28285983

Duffy J, Lewis M, Harrington T et al. Live attenuated influenza vaccine use and safety in children and adults with asthma. Ann Allergy Asthma Immunol 2017;118:439-444. https://www.ncbi.nlm.nih.gov/pubmed/28390584

Ray GT, Lewis N, Goddard K et al. Asthma exacerbations among asthmatic children receiving live attenuated versus inactivated influenza vaccines. Vaccine 2017. https://www.ncbi.nlm.nih.gov/pubmed/28404355

DeSilva M, Vazquez-Benitez G, Nordin JD et al. Maternal Tdap vaccination and risk of infant morbidity. Vaccine 2017. – https://www.ncbi.nlm.nih.gov/pubmed/28552511

Kharbanda EO, Vazquez-Benitez G, Romitti PA et al. First Trimester Influenza Vaccination and Risks for Major Structural Birth Defects in Offspring. J Pediatr 2017;187:234-239. – https://www.ncbi.nlm.nih.gov/pubmed/28550954

Lipkind HS, Vazquez-Benitez G, Nordin JD et al. Maternal and Infant Outcomes After Human Papillomavirus Vaccination in the Periconceptional Period or During Pregnancy. Obstet Gynecol 2017. – https://www.ncbi.nlm.nih.gov/pubmed/28796684

McLean HQ, VanWormer JJ, Chow BDW et al. Improving Human Papillomavirus Vaccine Use in an Integrated Health System: Impact of a Provider and Staff Intervention. J Adolesc Health 2017;61:252-258. – https://www.ncbi.nlm.nih.gov/pubmed/28462786

Sukumaran L, Omer SB. Repeat Tdap Vaccination and Adverse Birth Outcomes–Reply. JAMA 2016;315:1286.   https://www.ncbi.nlm.nih.gov/pubmed/27002457

Duffy J, Weintraub E, Hambidge SJ et al. Febrile Seizure Risk After Vaccination in Children 6 to 23 Months. Pediatrics 2016.   https://www.ncbi.nlm.nih.gov/pubmed/27802536

Vazquez-Benitez G, Kharbanda EO, Naleway AL et al. Risk of Preterm or Small-for-Gestational-Age Birth After Influenza Vaccination During Pregnancy: Caveats When Conducting Retrospective Observational Studies. Am J Epidemiol 2016;184:176-186.   https://www.ncbi.nlm.nih.gov/pubmed/27449414

Baxter R, Lewis E, Goddard K et al. Acute demyelinating events following vaccines – a case centered analysis. Clin Infect Dis 2016.   https://www.ncbi.nlm.nih.gov/pubmed/27585798

DeSilva M, Vazquez-Benitez G, Nordin JD et al. Tdap Vaccination During Pregnancy and Microcephaly and Other Structural Birth Defects in Offspring. JAMA 2016;316:1823-1825.   https://www.ncbi.nlm.nih.gov/pubmed/27802536

Glanz JM, Newcomer SR, Jackson ML, Omer SB, Bednarczyk RA, Shoup JA, Daley MF: Vaccine Safety Datalink. White Paper on Studying the Safety of the Childhood Immunization Schedule [PDF – 896K]

Kharbanda EO, Vazquez-Benitez G, Lipkind HS et al. Maternal Tdap vaccination: Coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013. Vaccine 2016.

McCarthy NL, Gee J, Sukumaran L et al. Vaccination and 30-Day Mortality Risk in Children, Adolescents, and Young Adults. Pediatrics 2016;137:1-8.

Tartof SY, Qian L, Rieg GK et al. Safety of Seasonal Influenza Vaccination in Hospitalized Surgical Patients: A Cohort Study. Ann Intern Med 2016.

Li R, Stewart B, McNeil MM et al. Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013-2014 and 2014-2015 seasons. Pharmacoepidemiol Drug Saf 2016.

Gee J, Weinbaum C, Sukumaran L, Markowitz LE. Quadrivalent HPV vaccine safety review and US safety monitoring plans for nine-valent HPV vaccine. Hum Vaccin Immunother 2016;0.

Baxter R, Lewis E, Fireman B, DeStefano F, Gee J, Klein NP. Case-centered analysis of Optic Neuritis following vaccines. Clin Infect Dis 2016.

Abrams JY, Weintraub ES, Baggs JM, McCarthy NL, Schonberger LB, Lee GM, et al. Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006. Vaccine. 2015 Jan 3;33(2):382-7.

Duffy J, Weintraub E, Vellozzi C, DeStefano F; Vaccine Safety Datalink. Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States. Neurology. 2014 Nov 11;83(20):1823-30. Epub 2014 Oct 15.

Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Klein NP, Cheetham TC, Naleway A, et al. Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes. JAMA. 2014 Nov 12;312(18):1897-904.

Klein NP, Lewis E, Fireman B, Hambidge SJ, Naleway A, Nelson JC, et al. Safety of measles-containing vaccines in 1-Year-Old children. Pediatrics. 2015 Feb;135(2):e321-9. Epub 2015 Jan 5.

McNamara LA, Shumate AM, Johnsen P, MacNeil JR, Patel M, Bhavsar T, et al. First use of a serogroup B meningococcal vaccine in the us in response to a university outbreak. Pediatrics. 2015 May;135(5):798-804.

McNeil MM, Weintraub E, Duffy J, Sukumaran L,  Jacobsen SJ, Klein NP, et al. Risk of anaphylaxis following vaccination in children and adults. J Allergy Clin Immunol. Epub 2015 Sep 28.

Payne DC, Baggs J, Klein NP, Parashar UD. Does preventing rotavirus infections through vaccination also protect against naturally occurring intussusception over time? Clin Infect Dis. 2015 Jan 1;60(1):163-4.

Stratton KG, Cook AJ, Jackson LA, Nelson JC. Simulation study comparing exposure matching with regression adjustment in an observational safety setting with group sequential monitoring. Stat Med. 2015 Mar 30;34(7):1117-33.

Sukumaran L, McCarthy NL, Kharbanda EO, McNeil MM, Naleway AL, Klein NP, et al. Association of Tdap vaccination with acute events and adverse birth outcomes among pregnant women with prior tetanus-containing immunizations. JAMA. 2015 Oct 20;314(15):1581-1587.

Sukumaran L, McCarthy NL, Kharbanda EO, Weintraub ES, Vasquez-Benitez G, McNeil MM, et al. Safety of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis and influenza vaccinations in pregnancy. Obstet Gynecol. 2015 Nov;126(5):1069-74.

Sukumaran L, McCarthy NL, Li R, Weintraub ES, Jacobsen SJ, Hambidge SJ, et al. Demographic characteristics of members of the Vaccine Safety Datalink (VSD): A comparison with the United States population. Vaccine. 2015 Aug 26;33(36):4446-50. Epub 2015 Jul 23.

Daley MF, Yih WK, Glanz JM, Hambidge SJ, Narwaney KJ, Yin R, et al. Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. Vaccine. 2014;32(25):3019-3024.

Duffy J, Weintraub, E, Vellozzi, C, DeStefano F. Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States. Neurology. 2014;83(20):1823-30.

Hambidge SJ, Newcomer SR, Narwaney KJ, Glanz JM, Daley MF, Xu S, et al. Timely versus delayed early childhood vaccination and seizures. Pediatrics. 2014;133(6):e1492-e1499.

Jackson ML, Peterson D, Nelson JC, Greene SK, Jacobsen SJ, Belongia EA, et al. Using winter 2009-2010 to assess the accuracy of methods which estimate influenza-related morbidity and mortality. Epidemiol Infect. 2014 Dec 12:1-9.

Kawai AT, Li L, Kulldorff M, Vellozzi C, Weintraub E, Baxter R, et al. Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barre syndrome, encephalitis, or anaphylaxis in the 2012-2013 season. Pharmacoepidemiol Drug Saf. 2014;23(5):548-553.

Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Klein NP, Cheetham TC, Naleway A, et al. Evaluation of the Association of Maternal Pertussis Vaccination With Obstetric Events and Birth Outcomes. JAMA. 2014;312(18):1897-1904.

Kharbanda EO, Vazquez-Benitez G, Lipkind H, Naleway AL, Klein NP, Cheetham TC, et al. Receipt of pertussis vaccine during pregnancy across 7 Vaccine Safety Datalink sites. Prev Med. 2014 Oct;67:316-9.

Li R, Stewart B, Weintraub E, McNeil MM. Continuous sequential boundaries for vaccine safety surveillance. Stat Med. 2014 Aug 30;33(19):3387-3397.

McNeil MM, Gee J, Weintraub ES, Belongia EA, Lee GM, Glanz JM, et al. The Vaccine Safety Datalink: Successes and challenges monitoring vaccine safety. Vaccine. 2014 Sep 22;32(42):5390-5398.

Naleway AL, Irving SA, Henninger ML, Li DK, Shifflett P, Ball S, et al. Safety of influenza vaccination during pregnancy: A review of subsequent maternal obstetric events and findings from two recent cohort studies. Vaccine. 2014;32(26):3122-3127.

Naleway AL, Kurosky S, Henninger ML, Gold R, Nordin JD, Kharbanda EO, et al. Vaccinations given during pregnancy, 2002-2009: A descriptive study. Am J Prev Med. 2014;46(2):150-157.

Nelson JC, Shortreed SM, Yu O, Peterson D, Baxter R, Fireman B, et al. Integrating database knowledge and epidemiological design to improve the implementation of data mining methods to evaluate vaccine safety in large healthcare databases. Stat Analysis Data Mining. 2014 Oct;7(5):337–351.

Nordin JD, Kharbanda EO, Vazquez-Benitez G, Lipkind H, Lee GM, Naleway AL. Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse events. Vaccine. 2014 Sep 3;32(39):4985-4992.

Nordin JD, Kharbanda EO, Vazquez Benitez G, Lipkind H, Vellozzi C, Destefano F, et al. Maternal influenza vaccine and risks for preterm or small for gestational age birth. J Pediatr. 2014;164(5):1051-1057.

Tartof SY, Tseng HF, Liu IL, Qian L, Sy LS, Hechter RC, et al. Inpatient admission for febrile seizure and subsequent outcomes do not differ in children with vaccine-associated versus non-vaccine associated febrile seizures. Vaccine. 2014;32(48):6408-14.

Tartof SY, Tseng HF, Liu AL, Qian L, Sy LS, Hechter RC, et al. Exploring the risk factors for vaccine-associated and non-vaccine associated febrile seizures in a large pediatric cohort. Vaccine. 2014;32(22):2574-2581.

Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, et al. Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med. 2014;370(6):513-519.

Xu S, Newcomer S, Nelson J, Qian L, McClure D, Pan Y, et al. Signal detection of adverse events with imperfect confirmation rates in vaccine safety studies using self-controlled case series design. Biom J. 2014;56(3):513-525.

Baxter R, Bakshi N, Fireman B, Lewis E, Ray P, et al. Lack of association of Guillain-Barré syndrome with vaccinations. Clin Infect Dis. 2013; 57(2):197-204.

DeStefano F, Price CS, Weintraub ES. Increasing exposure to antibody-stimulating proteins and polysaccharides in vaccines is not associated with risk of autism. J Pediatr. 2013;163(2):561-567.

Dodd CN, Romio SA, Black S, Vellozzi C, Andrews N, Sturkenboom M, et al. International collaboration to assess the risk of Guillain Barre Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine. 2013;31(40):4448-4458.

Glanz JM, Narwaney KJ, Newcomer SR, Daley MF, Hambidge SJ, Rowhani-Rahbar A, et al. Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age. JAMA Pediatr. 2013;167(11):1060-1064.

Glanz JM, Newcomer SR, Narwaney KJ, Hambidge SJ, Daley MF, Wagner NM, et al. A population-based cohort study of undervaccination in 8 managed care organizations across the United States. JAMA Pediatr. 2013;167(3):274-281.

Gold R, Naleway A, Riedlinger K. Factors predicting completion of the human papillomavirus vaccine series. J Adolesc Health. 2013;52(4):427-432.

Greene SK, Li L, Shay DK, Fry AM, Lee GM, Jacobsen SJ, et al. Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010. Pharmacoepidemiol Drug Saf. 2013;22(4):335-344.

Greene SK, Rett MD, Vellozzi C, Li L, Kulldorff M, Marcy SM,et al. Guillain-Barre syndrome, influenza vaccination, and antecedent respiratory and gastrointestinal infections: A case-centered analysis in the Vaccine Safety Datalink, 2009-2011. PLoS One. 2013;8(6):e67185.

Henninger M, Crane B, Naleway A. Trends in influenza vaccine coverage in pregnant women, 2008 to 2012. Perm J. 2013;17(2):31-36.

Henninger M, Naleway A, Crane B, Donahue J, Irving S. Predictors of seasonal influenza vaccination during pregnancy. Obstet Gynecol. 2013;121(4):741-749.

Iqbal S, Barile JP, Thompson WW, DeStefano F. Number of antigens in early childhood vaccines and neuropsychological outcomes at age 7-10 years. Pharmacoepidemiol Drug Saf. 2013;22(12):1263-1270.

Irving SA, Kieke BA, Donahue JG, Mascola MA, Baggs J, DeStefano F, et al. Trivalent inactivated influenza vaccine and spontaneous abortion. Obstet Gynecol. 2013;121(1):159-165.

Jackson ML, Yu O, Nelson JC, Naleway A, Belongia EA, Baxter R, et al. Further evidence for bias in observational studies of influenza vaccine effectiveness: The 2009 influenza A(H1N1) pandemic. Am J Epidemiol. 2013;178(8):1327-1336.

Jackson LA, Peterson D, Nelson JC, Marcy SM, Naleway AL, Nordin JD, et al. Vaccination site and risk of local reactions in children 1 through 6 years of age. Pediatrics. 2013;131(2):283-289.

Kharbanda EO, Vazquez-Benitez G, Lipkind H, Naleway A, Lee G, Nordin JD, et al. Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events. Obstet Gynecol. 2013;122(3):659-667.

Kharbanda EO, Vazquez-Benitez G, Shi WX, Lipkind H, Naleway A, Molitor B, et al. Assessing the safety of influenza immunization during pregnancy: The Vaccine Safety Datalink. Am J Obstet Gynecol. 2012;207(3 Suppl):S47-S51.

McCarthy NL, Gee J, Lin ND, Thyagarajan V, Pan Y, Su S. Evaluating the safety of influenza vaccine using a claims-based health system. Vaccine. 2013;31(50):5975-5982.

McCarthy NL, Irving S, Donahue JG, Weintraub E, Gee J, Belongia E. Vaccination coverage levels among children enrolled in the Vaccine Safety Datalink. Vaccine. 2013;31(49):5822-5826.

McCarthy NL, Weintraub E, Vellozzi C, Duffy J, Gee J, Donahue JG. Mortality rates and cause-of-death patterns in a vaccinated population. Am J Prev Med. 2013;45(1):91-97.

Naleway AL, Gold R, Kurosky S, Riedlinger K, Henninger ML, Nordin JD, et al. Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink. Vaccine. 2013;31(27):2898-2903.

Nelson JC, Yu O, Dominguez-Islas CP, Cook AJ, Peterson D, Greene SK, et al. Adapting group sequential methods to observational postlicensure vaccine safety surveillance: Results of a pentavalent combination DTaP-IPV-Hib vaccine safety study. Am J Epidemiol. 2013;177(2):131-141.

Nelson JC, Marsh T, Lumley T, Larson EB, Jackson LA, Jackson M, et al. Validation sampling can reduce bias in health care database studies: An illustration using influenza vaccination effectiveness. J Clin Epidemiol. 2013;66(8 Suppl):S110-S121.

Newcomer SR, Hambidge SJ, McClure DL, Daley MF, Klein NP, Glanz JM. Factors that may explain observed associations between trivalent influenza vaccination and gastrointestinal illness in young children. Vaccine. 2013;31(37):3894-3898.

Nordin JD, Parker ED, Vazquez-Benitez G, Kharbanda EO, Naleway A, Marcy SM, et al. Safety of the yellow fever vaccine: A retrospective study. J Travel Med. 2013;20(6):368-373.

Nordin JD, Kharbanda EO, Benitez GV, Nichol K, Lipkind H, Naleway A, et al. Maternal safety of trivalent inactivated influenza vaccine in pregnant women. Obstet Gynecol. 2013;121(3):519-525.

Qian L, Tseng HF, Sy LS, Jacobsen SJ. Confounder adjustment in vaccine safety studies: Comparing three offset terms for case-centered approach. Vaccine. 2013;31(2):431-435.

Salmon DA, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen DR, et al. Association between Guillain-Barre syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: A meta-analysis. Lancet. 2013;381(9876):1461-1468.

Schmidt MA, Gold R, Kurosky SK, Daley MF, Irving SA, Gee J, et al. Uptake, coverage, and completion of quadrivalent human papillomavirus vaccine in the Vaccine Safety Datalink, July 2006-June 2011. J Adolesc Health. 2013;53(5):637-641.

Tseng HF, Sy LS, Liu IL, Qian L, Marcy SM, Weintraub E, et al. Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children. Vaccine. 2013;31(22):2578-2583.

Xu S, Hambidge SJ, McClure DL, Daley MF, Glanz JM. A scan statistic for identifying optimal risk windows in vaccine safety studies using self-controlled case series design. Stat Med. 2013;32(19):3290-3299.

Zeng C, Newcomer SR, Glanz JM, Shoup JA, Daley MF, Hambidge SJ, et al. Bias correction of risk estimates in vaccine safety studies with rare adverse events using a self-controlled case series design. Am J Epidemiol.2013;178(12):1750-1759.

Greene SK, Rett M, Weintraub ES, Li L, Yin R, Amato AA, et al. Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink project, 2009-2010. Am J Epidemiol. 2012;175(11):1100-1109.

Greene SK, Shay DK, Yin R, McCarthy NL, Baxter R, Jackson ML, et al. Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010. Influenza Other Respir Viruses.2012;6(6):e143-e151.

Hambidge SJ, Ross C, Glanz J, McClure D, Daley MF, Xu S, et al. Trivalent inactivated influenza vaccine is not associated with sickle cell crises in children. Pediatrics. 2012;129(1):e54-e59.

Hechter RC, Qian L, Sy LS, Greene SK, Weintraub ES, Naleway AL, et al. Secular trends in diagnostic code density in electronic healthcare data from health care systems in the Vaccine Safety Datalink project. Vaccine. 2012;31(7):1080-1085.

Klein NP, Lewis E, Baxter R, Weintraub E, Glanz J, Naleway A, et al. Measles-containing vaccines and febrile seizures in children age 4 to 6 years. Pediatrics. 2012;129(5):809-814.

McClure DL, Xu S, Weintraub E, Glanz JM. An efficient statistical algorithm for a temporal scan statistic applied to vaccine safety analyses. Vaccine. 2012;30(27):3986-3991.

Naleway AL, Gold R, Drew L, Riedlinger K, Henninger ML, Gee J. Reported adverse events in young women following quadrivalent human papillomavirus vaccination. J Womens Health (Larchmt.). 2012;21(4):425-432.

Rowhani-Rahbar A, Baxter R, Rasgon B, Ray P, Black S, Klein JO, et al. Epidemiologic and clinical features of Bell’s palsy among children in northern California. Neuroepidemiology. 2012;38(4):252-258.

Rowhani-Rahbar A, Fireman B, Lewis N, Ray P, Rasgon B, Klein JO, et al. Rowhani-Rahbar et al. respond to “Immunization and Bell’s palsy in children.” Am J Epidemiol. 2012;175(9):888-889.

Rowhani-Rahbar A, Klein NP, Lewis N, Fireman B, Ray P, Rasgon B, et al. Immunization and Bell’s palsy in children: A case-centered analysis. Am J Epidemiol. 2012;175(9):878-885.

Shui IM, Baggs J, Patel M, Parashar UD, Rett M, Belongia EA, et al. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA. 2012;307(6):598-604.

Shui IM, Rett MD, Weintraub E, Marcy M, Amato AA, Sheikh SI, et al. Guillain-Barré syndrome incidence in a large United States cohort (2000-2009). Neuroepidemiology. 2012;39(2):109-115.

Tse A, Tseng HF, Greene SK, Vellozzi C, Lee GM, VSD Rapid Cycle Analysis Influenza Working Group. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011. Vaccine. 2012;30(11):2024-2031.

Tseng HF, Sy LS, Qian L, Marcy SM, Jackson LA, Glanz J, et al. Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population. Clin Infect Dis. 2012;56(3):315-321.

Xu S, Zeng C, Newcomer S, Nelson J, Glanz J. Use of fixed effects models to analyze self-controlled case series data in vaccine safety studies. J Biom Biostat. 2012;Suppl 7:006.

Yih WK, Weintraub E, Kulldorff M. No risk of Guillain-Barré syndrome found after meningococcal conjugate vaccination in two large cohort studies. Pharmacoepidemiol Drug Saf. 2012;21(12):1359-1360.

Baggs J, Gee J, Lewis E, Fowler G, Benson P, Lieu T, et al. The Vaccine Safety Datalink: A model for monitoring immunization safety. Pediatrics. 2011;127(Supp 1):S45-S53.

Barile JP, Kuperminc GP, Weintraub ES, Mink JW, Thompson WW, et al. Thimerosal exposure in early life and neuropsychological outcomes 7-10 years later. J Pediatr Psychol. 2011;37(1):106-118.

Gee J, Naleway A, Shui I, Baggs J, Yin R, Li R, et al. Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink. Vaccine. 2011;29(46):8279-8284.

Glanz JM, Newcomer SR, Hambidge SJ, Daley MF, Narwaney KJ, Xu S, et al. Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the Vaccine Safety Datalink. Arch Pediatr Adolesc Med.2011;165(8):749-755.

Greene SK, Kulldorff M, Yin R, Yih WK, Lieu TA, Weintraub ES, et al. Near real-time vaccine safety surveillance with partially accrued data. Pharmacoepidemiol Drug Saf. 2011;20(6):583-590.

Hambidge SJ, Ross C, McClure D, Glanz J; VSD team. Trivalent inactivated influenza vaccine is not associated with sickle cell hospitalizations in adults from a large cohort. Vaccine. 2011;29(46):8179-8181.

Jackson LA, Yu O, Nelson JC, Dominguez C, Peterson D, Baxter R, et al. Injection site and risk of medically attended local reactions to acellular pertussis vaccine. Pediatrics. 2011;127(3):e581-e587.

Jackson LA, Peterson D, Dunn J, Hambidge SJ, Dunstan M, Starkovichet P. A randomized placebo-controlled trial of acetaminophen for prevention of post-vaccination fever in infants. PLoS One. 2011;6(6):e20102.

Kulldorff M, Davis RL, Kolczak M, Lewis E, Lieu T, Platt R. A maximized sequential probability ratio test for drug and vaccine safety surveillance. Sequential Analysis. 2011;30(1):58-78.

Lee GM, Greene SK, Weintraub ES, Baggs J, Kulldorff M, Fireman BH. H1N1 and seasonal influenza vaccine safety in the Vaccine Safety Datalink project. Am J Prev Med. 2011;41(2):121-128.

McCarthy NL, Gee J, Weintraub E, Donahue JG, Nordin JD, Daley MF, et al. Monitoring vaccine safety using the Vaccine Safety Datalink: Utilizing immunization registries for pandemic influenza. Vaccine. 2011;29(31):4891-4896.

Mullooly JP, Schuler R, Mesa J, Drew L, DeStefano F; VSD team. Wheezing lower respiratory disease and vaccination of premature infants. Vaccine. 2011;29(44):7611-7617.

Nelson JC, Cook AJ, Yu O, et al. Methods for observational post-licensure medical product safety surveillance. Stat Methods Med Res. Epub 2 Dec 2011.

Ray P, Black S, Shinefield H, et al. Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age. Vaccine. 2011;29(38):6592-6597.

Tseng HF, Liu A, Sy L, Marcy SM, Fireman B, Weintraub E, et al. Safety of zoster vaccine in adults from a large managed care cohort: A Vaccine Safety Datalink study. J Intern Med. 2011;271(5):510-520.

Yih WK, Kulldorff M, Fireman BH, Shui IM, Lewis EM, Klein NP, et al. Active surveillance for adverse events: The experience of the Vaccine Safety Datalink project. Pediatrics. 2011;127(Suppl 1):S54-S64.

Belongia EA, Irving SA, Shui IM, Kulldorff M, Lewis E, et al. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J. 2010;29(1):1-5.

Donahue JG, Kieke BA, Gargiullo PM, Jumaan AO, Berger NR, McCauley JS, et al. Herpes zoster and exposure to the varicella zoster virus in an era of varicella vaccination. Am J Public Health. 2010;100(6):1116-1122.

Goodman MJ, Nordin JD, Belongia EA, Mullooly JP, Baggs J, et al. Henöch-Schonlein purpura and polysaccharide meningococcal vaccine. Pediatrics. 2010;126(2):e325-e329.

Greene SK, Kulldorff M, Lewis EM, Li R, Yin R, Weintraub ES, et al. Near real-time surveillance for influenza vaccine safety: Proof-of-concept in the Vaccine Safety Datalink project. Am J Epidemiol. 2010;171(2):177-188.

Huang WT, Gargiullo PM, Broder KR, Weintraub ES, Iskander JK, Klein NP, et al. Lack of association between acellular pertussis vaccine and seizures in early childhood. Pediatrics. 2010;126(2):263-269.

Klein NP, Fireman B, Yih WK, Lewis E, Kulldorff M, Ray P, et al. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics. 2010;126(1):e1-e8.

Li L, Kulldorff M. A conditional maximized sequential probability ratio test for pharmacovigilance. Stat Med. 2010;29(2):284-295.
Lin ND, Kleinman K, Chan KA, Soumerai S, Mehta J, Mullooly JP, et al. Multiple vaccinations and the risk of medically attended fever. Vaccine. 2010;28(25):4169-4174.

Price CS, Thompson WW, Goodson B, Weintraub ES, Croen LA, Hinrichsen VL, et al. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics. 2010;126(4):656-664.

Schmidt MA, Crane B, Mullooly JP, Naleway AL. Frequency of medically attended events following rapid revaccination with trivalent inactivated influenza vaccine. Vaccine. 2010;28(49):7713-7715.

Sy LS, Liu IL, Solano Z, Cheetham TC, Lugg MM, Greene SK, et al. Accuracy of influenza vaccination status in a computer-based immunization tracking system of a managed care organization. Vaccine. 2010 Jul 19;28(32):5254-9.

Xu S, Gargiullo P, Mullooly J, McClure D, Hambidge SJ,  Glanz J. Fitting parametric and semi-parametric conditional poisson regression models with Cox’s partial likelihood in self-controlled case series and matched cohort studies. [PDF – 95 KB] J Data Sci. 2010;8:349-360.

Xu S, Zhang L, Nelson JC, Zeng C, Mullooly J, McClure D, et al. Identifying optimal risk windows for self-controlled case series studies of vaccine safety. Stat Med. 2010;30(7):742-752.

Zangwill KM, Yeh SH, Wong EJ, Marcy SM, Eriksen E, Huff KR, et al. Paralytic syndromes in children: epidemiology and relationship to vaccination. Pediatr Neurol. 2010;42(3):206-212.

Batra JS, Eriksen EM, Zangwill KM, Lee M, Marcy SM, Ward JI, et al. Evaluation of vaccine coverage for low birth weight infants during the first year of life in a large managed care population. Pediatrics. 2009;123(3):951-958.

Donahue JG, Kieke BA, Yih WK, Berger NR, McCauley JS, Baggs J, et al. Varicella vaccination and ischemic stroke in children: Is there an association? Pediatrics. 2009;123(2):e228-e234.

Greene SK, Shi P, Dutta-Linn MM, Shoup JA, Hinrichsen VL, Ray P, et al. Accuracy of data on influenza vaccination status at four Vaccine Safety Datalink sites. Am J Prev Med. 2009;37(6):552-555.

Harris K, Baggs J, Davis RL, Black S, Jackson LA, Mullooly JP, et al. Influenza vaccination coverage among adult solid organ transplant recipients at three health maintenance organizations, 1995-2005. Vaccine. 2009;27(17):2335-2341.

Hazlehurst B, Naleway A, Mullooly J. Detecting possible vaccine adverse events in clinical notes of the electronic medical record. Vaccine. 2009;27(14):2077-2083.

Jackson LA, Baxter R, Naleway AL, Belongia EA, Baggs J. Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: A Vaccine Safety Datalink study. BMC Infect Dis. 2009;9:37.

Jackson LA, Yu O, Belongia EA, Hambidge SJ, Nelson J, Baxter R. Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: A Vaccine Safety Datalink study. BMC Infect Dis. 2009;9:165.

Jackson LA, Yu O, Nelson J, Belongia EA, Hambidge SJ, Baxter R. Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: A Vaccine Safety Datalink study. Vaccine. 2009;27(36):4912-4916.

Lorick SA, Fishbein D, Weintraub E, Wortley PM, Lee GM, Zhou F, et al. Uptake of meningococcal conjugate vaccine among adolescents in large managed care organizations, United States, 2005: Demand, supply and seasonality. BMC Infect Dis. 2009;9:175.

Naleway AL, Belongia EA, Donahue JG, Kieke BA, Glanz JM; Vaccine Safety Datalink team. Risk of immune hemolytic anemia in children following immunization. Vaccine. 2009;27(52):7394-7397.

Nelson JC, Bittner RC, Bounds L, Zhao S, Baggs J, Donahue JG, et al. Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: Results from a Vaccine Safety Datalink study. Am J Public Health. 2009;99(Suppl 2):S389-S397.

Patel MM, Haber P, Baggs J, Zuber P, Bines JE, Parashar UD. Intussusception and rotavirus vaccination: A review of the available evidence. Expert Rev Vaccines. 2009;8(11):1555-1564.

Shui IM, Shi P, Dutta-Linn MM, Weintraub ES, Hambidge SJ, Nordin JD, et al. Predictive value of seizure ICD-9 codes for vaccine safety research. Vaccine. 2009;27(39):5307-5312.

Tate JE, Curns AT, Cortese MM, Weintraub ES, Hambidge S, Zangwill KM, et al. Burden of acute gastroenteritis hospitalizations and emergency department visits in US children that is potentially preventable by rotavirus vaccination: A probe study using the now-withdrawn rotashield vaccine. Pediatrics. 2009;123(3):744-749.

Wei F, Mullooly JP, Goodman M, McCarty MC, Hanson AM, Crane B, et al. Identification and characteristics of vaccine refusers. BMC Pediatr. 2009;9:18.

Yih WK, Nordin JD, Kulldorff M, Lewis E, Lieu TA, Shi P, et al. An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink. Vaccine. 2009;27(32):4257-4262.

Benson PJ, Jackson LA, Rees TG, Dunn JB. Changes in DT vaccine frequency and indications for use following introduction of DTaP vaccine. Hum Vaccin. 2008;4(3):234-237.

Clayton HA, Cortes MM, Payne DC, Bartlett DL, Zimmerman LA, Williams WG, et al. Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practices (ACIP)-recommended vaccination schedule–United States, February 2006-May 2007. MMWR. 2008;57(15):398-401.

France EK, Glanz J, Xu S, Hambidge S, Yamasaki K, Black SB, et al. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics. 2008;121(3):e687-e692.

Glanz J, France E, Xu S, Hayes T, Hambidge S, et al. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children. Pediatrics. 2008;121(3):e506-e512.

Haber P, Patel M, Izurieta HS, Baggs J, Gargiullo P, Weintraub E, et al. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics. 2008;121(6):1206-1212.

Klein NP, Massolo ML, Greene J, Dekker CL, Black S, Escobar GJ, et al. Risk factors for developing apnea after immunization in the neonatal intensive care unit. Pediatrics. 2008;121(3):463-469.

McClure DL, Glanz JM, Xu S, Hambidge SJ, Mullooly JP, Baggs J, et al. Comparison of epidemiologic methods for active surveillance of vaccine safety. Vaccine. 2008;26(26):3341-3345.

Mullooly JP, Donahue JG, DeStefano F, Baggs J, Eriksen E; VSD Data Quality Working Group. Predictive value of ICD-9-CM codes used in vaccine safety research. Methods Inf Med. 2008;47(4):328-335.

Weinmann S, Chun C, Mullooly JP, Riedlinger K, Houston H, Loparev VN, et al. Laboratory diagnosis and characteristics of breakthrough varicella in children. J Infect Dis. 2008;197(Suppl 2):S132-S138.

Young HA, Geier DA, Geier MR. Thimerosal exposure in infants and neurodevelopmental disorders: An assessment of computerized medical records in the Vaccine Safety Datalink. J Neurol Sci. 2008; 271(1-2):110-118.

Hinrichsen VL, Kruskal B, O’Brien MA, Lieu TA, Platt R, Vaccine Safety Datalink Team. Using electronic medical records to enhance detection and reporting of vaccine adverse events. J Am Med Inform Assoc. 2007;14(6):731-735.

Jackson ML, Nelson JC, Chen RT, Davis RL, Jackson LA, Vaccine Safety Datalink team. Vaccines and changes in coagulation parameters in adults on chronic warfarin therapy: A cohort study. Pharmacoepidemiol.Drug Saf. 2007;16(7):790-796.

Jackson LA, Neuzil KM, Nahm MH, Whitney CG, Yu O, Nelson JC. Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Vaccine. 2007;25(20):4029-4037.

Lieu TA, Kulldorff M, Davis RL, Lewis EM, Weintraub E, Yih K, et al. Real-time vaccine safety surveillance for the early detection of adverse events. Med Care. 2007;45(10 Suppl 2):S89-S95.

Mullooly JP, Bridges CB, Thompson WW, Chen J, Weintraub E, Jackson LA, et al. Influenza- and RSV-associated hospitalizations among adults. Vaccine. 2007;25(5):846-855.

Mullooly JP, Schuler R, Barrett M, Maher JE. Vaccines, antibiotics, and atopy. Pharmacoepidemiol Drug Saf. 2007;16(3):275-288.

Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, et al. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med. 2007;357(13):1281-1292.

Yu O, Bohlke K, Hanson CA, Delaney K, Rees TG, Zavitkovsky A, et al. Hepatitis B vaccine and risk of autoimmune thyroid disease: A Vaccine Safety Datalink study. Pharmacoepidemiol Drug Saf. 2007;16(7):736-745.

Averhoff F, Zucker J, Vellozzi C, Redd S, Woodfill C, Waterman S, et al. Adequacy of surveillance to detect endemic rubella transmission in the United States. Clin Infect Dis. 2006;43(Suppl 3):S151-S157.

CDC. Update: Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine–United States, June 2005-September 2006. MMWR. 2006;55(41):1120-1124.

CDC. Update: Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine–United States, October 2005-February 2006. MMWR.2006;55(13):364-366.

France EK, Smith-Ray R, McClure D, Hambidge S, Xu S, Yamasaki K, et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. Arch Pediatr Adolesc Med.2006;160(12):1277-1283.

Glanz JM, McClure DL, Xu S, Hambidge SJ, Lee M, Kolczak MS, et al. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. J Clin Epidemiol. 2006;59(8):808-818.

Hambidge SJ, Glanz JM, France EK, McClure D, Xu S, Yamasaki K, et al. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. JAMA. 2006;296(16):1990-1997.

Heffelfinger JD, Heckbert SR, Psaty BM, Weiss NS, Thompson WW, Bridges CB, et al. Influenza vaccination and risk of incident myocardial infarction. Hum Vaccin. 2006;2(4):161-166.

Jackson LA, Nelson JC, Whitney CG, Neuzil KM, Benson P, Malais D. Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink population. Vaccine. 2006;24(2):151-156.

Jackson LA, Neuzil KM, Baggs J, Davis RL, Black S, Yamasaki KM, et al. Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: A Vaccine Safety Datalink study. Pediatrics. 2006;118(5):2032-2037.

Lieberman P, Camargo CA, Jr., Bohlke K, Jick H, Miller RL, Sheikh A, et al. Epidemiology of anaphylaxis: Findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol. 2006;97(5):596-602.

Lin ND, Kleinman K, Chan KA, Yu X, France EK, Wei F, et al. Variation in hepatitis B immunization coverage rates associated with provider practices after the temporary suspension of the birth dose. BMC Pediatr. 2006;6:31.

Mullooly JP, Crane B, Chun C. Trivalent inactivated influenza vaccine safety in children: Assessing the contribution of telephone encounters. Vaccine. 2006;24(13):2256-2263.

Neuzil KM, Jackson LA, Nelson J, Klimov A, Cox N, Bridges CB, et al. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis.2006;194(8):1032-1039.

Prosser LA, Bridges CB, Uyeki TM, Hinrichsen VL, Meltzer MI, Molinari NM, et al. Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerg Infect Dis. 2006;12(10):1548-1558.

Ray P, Hayward J, Michelson D, Lewis E, Schwalbe J, Black S, et al. Encephalopathy after whole-cell pertussis or measles vaccination: Lack of evidence for a causal association in a retrospective case-control study. Pediatr Infect Dis J. 2006;25(9):768-773.

Belongia EA, Naleway A, Kieke B, Qutaishat S, Casey C, et al. Validation of a screening instrument to identify persons for exclusion from smallpox vaccination. Clin Infect Dis. 2005;40(4):620-623.

Davis RL, Kolczak M, Lewis E, Nordin J, Goodman M, Shay DK, et al. Active surveillance of vaccine safety: A system to detect early signs of adverse events. Epidemiology. 2005;16(3):336-341.

DeStefano F, Weintraub ES, Chen RT. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: A prospective study. Neurology. 2005;64(7):1317.

Hazlehurst B, Mullooly J, Naleway A, Crane B. Detecting possible vaccination reactions in clinical notes. AMIA Annu Symp Proc. 2005:306-310.

Jackson LA, Neuzil KM, Whitney CG, Starkovich P, Dunstan M, Yu O, et al. Safety of varying dosages of 7-valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Vaccine. 2005;23(28):3697-3703.

Lewis N, Black S, Weintraub E, Baggs J, Thompson W, DeStefano F, et al. Rapid assessment of influenza vaccination coverage among HMO members–northern California influenza seasons, 2001-02 through 2004-05. MMWR. 2005;54(27):676-678.

Lin ND, Kleinman K, Chan KA, Yu XJ, France EK, Xu S, et al. Impact of the introduction of pneumococcal conjugate vaccine on immunization coverage among infants. BMC Pediatr. 2005;5:43.

Mell LK, Ogren DS, Davis RL, Mullooly JP, Black SB, Shinefield HR, et al. Compliance with national immunization guidelines for children younger than 2 years, 1996-1999. Pediatrics. 2005;115(2):461-467.

Mullooly JP, Riedlinger K, Chun C, Weinmann S, Houston H. Incidence of herpes zoster, 1997-2002 [PDF – 120 KB]. Epidemiol Infect.2005;133(2):245-253.

Prosser LA, Bridges CB, Uyeki TM, Rêgo VH, Ray GT, Meltzer MI, et al. Values for preventing influenza-related morbidity and vaccine adverse events in children. Health Qual Life Outcomes. 2005;3:18.

Black SB, Shinefield HR, France EK, Fireman BH, Platt ST, et al. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol. 2004;21(6):333-339.

Bohlke K, Davis RL, DeStefano F, Marcy SM, Braun MM, et al. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol. 2004;113(3):536-542.

Eriksen EM, Perlman JA, Miller A, Marcy SM, Lee H, Vadheim C, et al. Lack of association between hepatitis B birth immunization and neonatal death: A population-based study from the Vaccine Safety Datalink project. Pediatr Infect Dis J. 2004;23(7):656-662.

France EK, Glanz JM, Xu S, Davis RL, Black SB, Shinefield HR, et al. Safety of the trivalent inactivated influenza vaccine among children: A population-based study. Arch Pediatr Adolesc Med. 2004;158(11):1031-1036.

Maher JE, Mullooly JP, Drew L, DeStefano F. Infant vaccinations and childhood asthma among full-term infants. Pharmacoepidemiol Drug Saf. 2004;13(1):1-9.

Mullooly J, Drew L, DeStefano F, Maher J, Bohlke K, Immanuel V, et al. Quality assessments of HMO diagnosis databases used to monitor childhood vaccine safety. Methods Inf Med. 2004;43(2):163-170.

Mullooly JP, Maher JE, Drew L, et al. Evaluation of the impact of an HMO’s varicella vaccination program on incidence of varicella. Vaccine. 2004;22(11-12):1480-1485.

O’Brien MA, Uyeki TM, Shay DK, Thompson WW, Kleinman K, McAdam A, et al. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics. 2004;113(3 Pt 1):585-593.

Spector L, Groves F, DeStefano F, Liff J, Klein M, Mullooly J, et al. Medically recorded allergies and the risk of childhood acute lymphoblastic leukaemia. Eur J Cancer. 2004;40(4):579-584.

Bohlke K, Davis RL, Marcy SM, Braun MM, DeStefano F, et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics. 2003;112(4):815-820

DeStefano F, Verstraeten T, Jackson LA, Okoro CA, Benson P, Black SB, et al. Vaccinations and risk of central nervous system demyelinating diseases in adults. Arch Neurol. 2003;60(4):504-509.

Jackson LA, Neuzil KM, Yu O, Benson P, Barlow WE, Adams AL, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med. 2003;348(18):1747-1755.

Mell LK, Davis RL, Mullooly JP, Black SB, Shinefield HR, Zangwill KM, et al. Polio extraimmunization in children younger than 2 years after changes in immunization recommendations. Pediatrics. 2003;111(2):296-301.

Naleway AL, Belongia EA, Greenlee RT, Kieke BA Jr, Chen RT, Shay DK. Eczematous skin disease and recall of past diagnoses: Implications for smallpox vaccination. Ann Intern Med. 2003;139(1):1-7.

Verstraeten T, Davis RL, DeStefano F, Lieu TA, Rhodes PH, Black SB, et al. Safety of thimerosal-containing vaccines: A two-phased study of computerized health maintenance organization databases. Pediatrics. 2003;112(5):1039-1048.

Verstraeten T, Jumaan AO, Mullooly JP, Seward JF, Izurieta HS, DeStefano F, et al. A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination. Pediatrics. 2003;112(2):e98-103.

Verstraeten T, DeStefano F, Chen RT, Miller E. Vaccine safety surveillance using large linked databases: Opportunities, hazards and proposed guidelines. Expert Rev Vaccines. 2003;2(1):21-29.

Yih WK, Lieu TA, Rego VH, O’Brien MA, Shay DK, Yokoeet DS, et al. Attitudes of healthcare workers in U.S. hospitals regarding smallpox vaccination. BMC Public Health. 2003;3:20.

Black SB, Lewis E, Shinefield HR, Fireman B, Ray P, et al. Lack of association between receipt of conjugate haemophilus influenzae type B vaccine (HbOC) in infancy and risk of type 1 (juvenile onset) diabetes: Long term follow-up of the HbOC efficacy trial cohort. Pediatr Infect Dis J. 2002;21(6):568-569.

Chang EJ, Zangwill KM, Lee H, Ward JI. Lack of association between rotavirus infection and intussusception: Implications for use of attenuated rotavirus vaccines. Pediatr Infect Dis J. 2002;21(2):97-102.

DeStefano F, Gu D, Kramarz P, Truman BI, Iademarco MF, Mullooly JP, et al. Childhood vaccinations and risk of asthma. Pediatr Infect Dis J. 2002;21(6):498-504.

DeStefano F, Verstraeten T, Chen RT. Hepatitis B vaccine and risk of multiple sclerosis. Expert Rev Vaccines. 2002;1(4):461-466.

Gonzalez IM, Averhoff FM, Massoudi MS, Yusuf H, DeStefano F, Kramarz P, et al. Hepatitis B vaccination among adolescents in 3 large health maintenance organizations. Pediatrics. 2002;110(5):929-934.

Jackson LA, Yu O, Heckbert SR, Psaty BM, Malais D, Barlow WE, et al. Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol. 2002;156(7):634-640.

Mullooly JP, Pearson J, Drew L, Schuler R, Maher J, Gargiullo P, et al. Wheezing lower respiratory disease and vaccination of full-term infants. Pharmacoepidemiol Drug Saf. 2002;11(1):21-30.

Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, Mullooly JP, et al. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med. 2001;345(9):656-661.

Chen RT, DeStefano F, Pless R, Mootrey G, Kramarz P, Hibbs B. Challenges and controversies in immunization safety. Infect Dis Clin North Am. 2001;15(1):21-39, viii.

Davis RL, Lieu TA, Mell LK, Capra AM, Zavitkovsky A, Quesenberry CP Jr, et al. Impact of the change in polio vaccination schedule on immunization coverage rates: A study in two large health maintenance organizations. Pediatrics. 2001;107(4):671-676.

Davis RL, Kramarz P, Bohlke K, Benson P, Thompson RS, Mullooly J, et al. Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: A case-control study from the Vaccine Safety Datalink project. Arch Pediatr Adolesc Med. 2001;155(3):354-359.

Davis RL, Bohlke K. Measles vaccination and inflammatory bowel disease: Controversy laid to rest? Drug Saf. 2001;24(13):939-946.

DeStefano F, Mullooly JP, Okoro CA, Chen RT, Marcy SM, Ward JI, et al. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics. 2001;108(6):E112.

DeStefano F. The Vaccine Safety Datalink project. Pharmacoepidemiol Drug Saf. 2001;10(5):403-406.

Jackson LA, Austin G, Chen RT, Stout R, DeStefano F, Gorse GJ, et al. Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors. Vaccine. 2001;19(32):4703-4709.

Kramarz P, DeStefano F, Gargiullo PM, Chen RT, Lieu TA, Davis RL, et al. Does influenza vaccination prevent asthma exacerbations in children? J Pediatr. 2001;138(3):306-310.

Kramarz P, France EK, DeStefano F, Black SB, Shinefield H, Ward JI, et al. Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis J. 2001;20(4):410-416.

Lewis E, Shinefield HR, Woodruff BA, Black SB, Destefano F, Chen RT. Safety of neonatal hepatitis B vaccine administration. Pediatr Infect Dis J. 2001;20(11):1049-1054.

Lieu TA, Davis RL, Capra AM, Mell LK, Quesenberry CP, Martin KE, et al. Variation in clinician recommendations for multiple injections during adoption of inactivated polio vaccine. Pediatrics. 2001;107(4):E49.

Belay ED, Holman RC, Clarke MJ, Destefano F, Shahriari, et al. The incidence of Kawasaki syndrome in West Coast health maintenance organizations. Pediatr Infect Dis J. 2000;19(9):828-832.

Chen RT, DeStefano F, Davis RL. The Vaccine Safety Datalink: Immunization research in health maintenance organizations in the US [PDF – 313 KB]. Bull World Health Organ. 2000;78(2):186-194.

Chen RT, Mootrey G, DeStefano F. Safety of routine childhood vaccinations: An epidemiological review. Paediatr Drugs 2000; 2:273-290.

DeStefano F. Opportunities for population-based clinical research using data from managed care organizations. In: Davis JR, ed. Managed Care Systems and Emerging Infections. Washington, D.C.: National Academy Press, 2000: 16-18.

Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342(4):232-239.

Kramarz P, DeStefano F, Gargiullo PM, Davis RL, Chen RT, Mullooly JP, et al. Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Arch Fam Med. 2000;9(7):617-623.

Kramarz P, DeStefano F, Gargiullo PM, Davis RL, Chen RT, Mullooly JP, et al. Influenza vaccination in children with asthma in health maintenance organizations. Vaccine. 2000;18(21):2288-2294.

Kuppermann M, Nease RF, Jr., Ackerson LM, Black SB, Shinefield HR, Lieu TA. Parents’ preferences for outcomes associated with childhood vaccinations. Pediatr Infect Dis J. 2000;19(2):129-133.

Lieu TA, Black SB, Ray GT, Martin KE, Shinefield HR, Weniger BG. The hidden costs of infant vaccination. Vaccine. 2000;19(1):33-41.

Davis RL, Rubanowice D, Shinefield HR, Lewis N, Gu D, Black SB, et al. Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization status. JAMA. 1999;282(6):547-553.

DeStefano F, Chen RT. Negative association between MMR and autism. Lancet. 1999;353(9169):1987-1988.

Gargiullo PM, Kramarz P, DeStefano F, Chen RT. Principles of epidemiological research on drug effects. [Letter] Lancet. 1999;353(9151):501.

Jackson LA, Benson P, Sneller VP, Butler JC, Thompson RS, Chen RT, et al. Safety of revaccination with pneumococcal polysaccharide vaccine. JAMA. 1999;281(3):243-248.

Mullooly J, Drew L, DeStefano F, Chen R, Okoro K, Swint E, et al. Quality of HMO vaccination databases used to monitor childhood vaccine safety. Am J Epidemiol. 1999;149(2):186-194.

Davis RL, Mell LK, Zavitkovsky A, Thompson RS, Lieu TA, Capra AM, et al. Impact of the sequential IPV/OPV schedule on vaccination coverage levels–United States, 1997. MMWR. 1998;47(47):1017-1019.

Lieu TA, Black SB, Takahashi H, Ray P, Capra AM, Shinefield HR, et al. Varicella serology among school age children with a negative or uncertain history of chickenpox. Pediatr Infect Dis J. 1998;17(2):120-125.

Lieu TA, Capra AM, Makol J, Black SB, Shinefield HR. Effectiveness and cost-effectiveness of letters, automated telephone messages, or both for underimmunized children in a health maintenance organization. Pediatrics. 1998;101(4):E3.

Niu MT, Rhodes P, Salive M, Lively T, Davis DM, Black S, et al. Comparative safety of two recombinant hepatitis B vaccines in children: Data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD). J Clin Epidemiol. 1998;51(6):503-510.

Parashar UD, Holman RC, Bresee JS, Clarke MJ, Rhodes PH, Davis RL, et al. Epidemiology of diarrheal disease among children enrolled in four West Coast health maintenance organizations. Pediatr Infect Dis J. 1998;17(7):605-611.

Udovic SL, Lieu TA, Black SB, Ray PM, Ray GT, Shinefield HR. Parent reports on willingness to accept childhood immunizations during urgent care visits. Pediatrics. 1998;102(4):E47.

Barlow WE. Global measures of local influence for proportional hazards regression models. Biometrics. 1997;53(3):1157-1162.

Black S, Shinefield H, Ray P, Lewis E, Chen R, et al. Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: An analysis of the Vaccine Safety Datalink (VSD) Project. Pediatr Infect Dis J. 1997;16(5):500-503.

Chen RT, Glasser JW, Rhodes PH, Davis RL, Barlow WE, Thompson RS. Vaccine Safety Datalink project: A new tool for improving vaccine safety monitoring in the United States. Pediatrics. 1997;99(6):765-773.

Davis RL, Marcuse E, Black S, Shinefield H, Givens B, Schwalbe J, et al. MMR2 immunization at 4 to 5 years and 10 to 12 years of age: A comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. Pediatrics. 1997;100(5):767-771.

Davis RL, Black S, Vadheim C, Shinefield H, Baker B, Pearson D, et al. Immunization tracking systems: Experience of the CDC Vaccine Safety Datalink sites. HMO Pract. 1997;11(1):13-17.

Lieu TA, Black SB, Ray P, Schwalbe JA, Lewis EM, Lavetter A, et al. Computer-generated recall letters for underimmunized children: How cost-effective? Pediatr Infect Dis J. 1997;16(1):28-33.

Ray P, Black S, Shinefield H, Dillon A, Schwalbe J, Holmes S, et al. Risk of chronic arthropathy among women after rubella vaccination. JAMA. 1997;278(7):551-556.

Barlow W. Measurement of interrater agreement with adjustment for covariates. Biometrics.1996;52(2):695-702.

Lieu TA, Black SB, Sorel ME, Ray P, Shinefield HR. Would better adherence to guidelines improve childhood immunization rates? Pediatrics. 1996;98(6 Pt 1):1062-1068.

Mullooly JP. Misclassification model for person-time analysis of automated medical care databases. Am J Epidemiol. 1996;144(8):782-792.

Thompson RS. What have HMOs learned about clinical prevention services? An examination of the experience at Group Health Cooperative of Puget Sound. Milbank Q. 1996;74(4):469-509.

Wassilak SG, Glasser JW, Chen RT, Hadler SC. Utility of large-linked databases in vaccine safety, particularly in distinguishing independent and synergistic effects. Ann NY Acad Sci. 1995;754:377-382.

Lieu TA, Black SB, Ray P, Chellino M, Shinefield HR, Adleret NE. Risk factors for delayed immunization among children in an HMO. Am J Public Health. 1994;84(10):1621-1625.

Pearson DC, Thompson RS. Evaluation of Group Health Cooperative of Puget Sound’s Senior Influenza Immunization Program. Public Health Rep. 1994;109(4):571-578.